{"id":28399,"date":"2025-03-01T21:25:23","date_gmt":"2025-03-01T13:25:23","guid":{"rendered":"https:\/\/flcube.com\/?p=28399"},"modified":"2025-03-01T21:25:25","modified_gmt":"2025-03-01T13:25:25","slug":"biocytogen-completes-deepseek-localization-integrates-with-thousand-mice-ten-thousand-antibodies-plan","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=28399","title":{"rendered":"Biocytogen Completes DeepSeek Localization, Integrates with “Thousand Mice, Ten Thousand Antibodies” Plan"},"content":{"rendered":"\n

On February 28, Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG: 2315<\/a>) announced that it has completed the localization deployment of DeepSeek and achieved full synergy with its core business, the “Thousand Mice, Ten Thousand Antibodies” program. This technological integration marks a new stage of intelligence and dataization in the early – stage R & D of antibody drugs.<\/p>\n\n\n\n

Synergy and Future Prospects<\/strong>
The synergy between DeepSeek and the “Thousand Mice, Ten Thousand Antibodies” program will provide global pharmaceutical companies with more precise and breakthrough antibody drug R & D solutions in the future, greatly accelerating the drug development process.<\/p>\n\n\n\n

Program Details and Achievements<\/strong>
Biocytogen launched the “Thousand Mice, Ten Thousand Antibodies” program in 2020, targeting over 1,000 potential antibody drug targets for antibody development on its self – developed RenMab, RenLite, and RenNano fully human antibody mouse platforms. To date, it has obtained over 500,000 fully human antibody sequences for more than 1,000 drug targets, covering various antibody formats such as monoclonal antibodies, bispecific antibodies, and nanobodies. These antibodies have the advantages of high affinity, low immunogenicity, and drugability. In the future, this fully human antibody molecule library will rapidly expand to the tens of millions.<\/p>\n\n\n\n

Combined Advantages<\/strong>
Biocytogen stated in the announcement that the combination of the “Thousand Mice, Ten Thousand Antibodies” antibody library and the DeepSeek platform can provide global pharmaceutical companies with new monoclonal, bispecific, and multispecific antibody frameworks. These frameworks have high affinity, low immunogenicity, and excellent drugability. With the help of the DeepSeek platform, global pharmaceutical companies can quickly screen out target antibody molecules with high drug potential from the tens of millions of antibody molecules in the “Thousand Mice, Ten Thousand Antibodies” library.<\/p>\n\n\n\n

DeepSeek’s Capabilities<\/strong>
DeepSeek can also design multispecific antibodies with specific functions, such as bispecific and multispecific antibodies, by simulating molecular interactions and obtaining molecular frameworks from the vast antibody library of “Thousand Mice, Ten Thousand Antibodies”. This enables the rapid development of innovative antibody drugs for various diseases, greatly accelerating the drug development process and meeting unmet clinical needs.-Fineline Info & Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

On February 28, Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG: 2315) announced that it has completed…<\/p>\n","protected":false},"author":1,"featured_media":28400,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7],"tags":[99,1519,3514,1214],"class_list":["post-28399","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","tag-ai","tag-biocytogen-pharmaceuticals","tag-deepseek","tag-hkg-2315"],"yoast_head":"\nBiocytogen Completes DeepSeek Localization, Integrates with "Thousand Mice, Ten Thousand Antibodies" Plan - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"On February 28, Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced that it has completed the localization deployment of DeepSeek and achieved full synergy with its core business, the "Thousand Mice, Ten Thousand Antibodies" program. This technological integration marks a new stage of intelligence and dataization in the early - stage R & D of antibody drugs.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=28399\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biocytogen Completes DeepSeek Localization, Integrates with "Thousand Mice, Ten Thousand Antibodies" Plan\" \/>\n<meta property=\"og:description\" content=\"On February 28, Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG: 2315) announced that it has completed the localization deployment of DeepSeek and achieved full synergy with its core business, the "Thousand Mice, Ten Thousand Antibodies" program. This technological integration marks a new stage of intelligence and dataization in the early - stage R & D of antibody drugs.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=28399\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-01T13:25:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-01T13:25:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/0101-png.avif\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28399#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28399\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Biocytogen Completes DeepSeek Localization, Integrates with “Thousand Mice, Ten Thousand Antibodies” Plan\",\"datePublished\":\"2025-03-01T13:25:23+00:00\",\"dateModified\":\"2025-03-01T13:25:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28399\"},\"wordCount\":348,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28399#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/0101-png.avif\",\"keywords\":[\"AI\",\"Biocytogen Pharmaceuticals\",\"DeepSeek\",\"HKG: 2315\"],\"articleSection\":[\"Company\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=28399#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28399\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=28399\",\"name\":\"Biocytogen Completes DeepSeek Localization, Integrates with \\\"Thousand Mice, Ten Thousand Antibodies\\\" Plan - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28399#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28399#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/0101-png.avif\",\"datePublished\":\"2025-03-01T13:25:23+00:00\",\"dateModified\":\"2025-03-01T13:25:25+00:00\",\"description\":\"On February 28, Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced that it has completed the localization deployment of DeepSeek and achieved full synergy with its core business, the \\\"Thousand Mice, Ten Thousand Antibodies\\\" program. This technological integration marks a new stage of intelligence and dataization in the early - stage R & D of antibody drugs.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28399#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=28399\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28399#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/0101-png.avif\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/0101-png.avif\",\"width\":1080,\"height\":608,\"caption\":\"Biocytogen Completes DeepSeek Localization, Integrates with 'Thousand Mice, Ten Thousand Antibodies' Plan\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28399#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biocytogen Completes DeepSeek Localization, Integrates with “Thousand Mice, Ten Thousand Antibodies” Plan\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Biocytogen Completes DeepSeek Localization, Integrates with \"Thousand Mice, Ten Thousand Antibodies\" Plan - Insight, China's Pharmaceutical Industry","description":"On February 28, Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced that it has completed the localization deployment of DeepSeek and achieved full synergy with its core business, the \"Thousand Mice, Ten Thousand Antibodies\" program. This technological integration marks a new stage of intelligence and dataization in the early - stage R & D of antibody drugs.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=28399","og_locale":"en_US","og_type":"article","og_title":"Biocytogen Completes DeepSeek Localization, Integrates with \"Thousand Mice, Ten Thousand Antibodies\" Plan","og_description":"On February 28, Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG: 2315) announced that it has completed the localization deployment of DeepSeek and achieved full synergy with its core business, the \"Thousand Mice, Ten Thousand Antibodies\" program. This technological integration marks a new stage of intelligence and dataization in the early - stage R & D of antibody drugs.","og_url":"https:\/\/flcube.com\/?p=28399","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-03-01T13:25:23+00:00","article_modified_time":"2025-03-01T13:25:25+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/0101-png.avif","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=28399#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=28399"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Biocytogen Completes DeepSeek Localization, Integrates with “Thousand Mice, Ten Thousand Antibodies” Plan","datePublished":"2025-03-01T13:25:23+00:00","dateModified":"2025-03-01T13:25:25+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=28399"},"wordCount":348,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=28399#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/0101-png.avif","keywords":["AI","Biocytogen Pharmaceuticals","DeepSeek","HKG: 2315"],"articleSection":["Company"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=28399#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=28399","url":"https:\/\/flcube.com\/?p=28399","name":"Biocytogen Completes DeepSeek Localization, Integrates with \"Thousand Mice, Ten Thousand Antibodies\" Plan - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=28399#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=28399#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/0101-png.avif","datePublished":"2025-03-01T13:25:23+00:00","dateModified":"2025-03-01T13:25:25+00:00","description":"On February 28, Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced that it has completed the localization deployment of DeepSeek and achieved full synergy with its core business, the \"Thousand Mice, Ten Thousand Antibodies\" program. This technological integration marks a new stage of intelligence and dataization in the early - stage R & D of antibody drugs.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=28399#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=28399"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=28399#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/0101-png.avif","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/0101-png.avif","width":1080,"height":608,"caption":"Biocytogen Completes DeepSeek Localization, Integrates with 'Thousand Mice, Ten Thousand Antibodies' Plan"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=28399#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Biocytogen Completes DeepSeek Localization, Integrates with “Thousand Mice, Ten Thousand Antibodies” Plan"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/0101-png.avif","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/28399","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=28399"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/28399\/revisions"}],"predecessor-version":[{"id":28401,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/28399\/revisions\/28401"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/28400"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=28399"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=28399"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=28399"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}